Veterinary Medicines

IVERTIN 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs

Authorised
  • Ivermectin
Download as PDF

Product identification

Medicine name:
IVERTIN 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs
Ivertin 10 mg/ml solução injetável para bovinos, ovinos e suínos
Active substance:
  • Ivermectin
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Ivermectin
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        49
        day
    • Sheep
      • Meat and offal
        22
        day
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 12 vial of 50 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 10 vial of 500 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 6 vial of 500 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 12 vial of 100 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 10 vial of 100 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring.6 vials of 100 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 12 vials of 500 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 10 vials of 50 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 6 vials of 50 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 1 vial of 500 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 1 vial of 100 ml.
  • Polypropylene vials provided with grey stoppers of bromobutyl type I and metallic aluminium capsules with blue flip-off ring. 1 vial of 50 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Calier Portugal Medicamentos E Produtos Veterinarios S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 983/01/16DFVPT
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/0122/001
Concerned member states:
  • Austria
  • Croatia
  • Greece
  • Italy
  • Romania
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 17/11/2021
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 22/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."